<DOC>
	<DOCNO>NCT01889342</DOCNO>
	<brief_summary>Comorbidity normal clinical practice . Metacognitive Therapy ( MCT ) transdiagnostic model could therefore well suit come treat patient high rate comorbidity . So far , study examine MCT comparison best document evidence base treatment , cognitive behavioral treatment ( CBT ) , randomize control trial consist mixed anxiety disorder sample high degree comorbidity . The main aim study 1 ) Evaluate effectiveness metacognitive therapy sample mixed anxiety disorder compare group receive exist evidence-based single diagnosis CBT- treatment protocols 2 ) Investigate pattern mechanism change two treatment .</brief_summary>
	<brief_title>Metacognitive Therapy Versus Cognitive Behavioral Therapy Mixed Anxiety Disorders : A Randomized Controlled Trial .</brief_title>
	<detailed_description />
	<mesh_term>Disease</mesh_term>
	<mesh_term>Anxiety Disorders</mesh_term>
	<criteria>DSM IV diagnose SAD , PD/A PTSD ( CSR &gt; 4 ) Withdraw psychotropic medication treatment Psychosis Not willing accept randomization Comorbid condition immediate need treatment</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>March 2016</verification_date>
	<keyword>MCT</keyword>
	<keyword>Metacognitive therapy</keyword>
	<keyword>Anxiety disorder</keyword>
	<keyword>Transdiagnostic</keyword>
</DOC>